Biocon Pharma Limited
Biocon Pharma Limited is a Public Non-govt company company incorporated in 2014 and based in Karnataka, India. Biocon Pharma Limited operates in Allopathic pharmaceutical preparations, manufacturing (NIC 24232) with authorized capital of ₹1040.00 Cr and paid-up capital of ₹14.05 Cr. For 2014-15, the company reported revenue of ₹0 and a net loss of ₹1.00 L. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +16d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +23d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Biocon Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 209145629 | ICICI Bank Ltd(Bank) | ₹9.57 Cr | 27 Jan 2022 | Satisfied |
| 722732481 | Axis Bank Ltd(Bank) | ₹18.22 Cr | 12 Mar 2020 | Satisfied |
| 859909447 | ICICI Bank Ltd(Bank) | ₹21.26 Cr | 27 Jan 2023 | Satisfied |
| 621786480 | State Bank of India(Bank) | ₹23.82 Cr | 19 Sep 2022 | Open |
Charge IDs, lenders & amounts for Biocon Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2014-15 | — |
Detailed Financials
1 FYs| Line item | 2014-15 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹31.91 Cr | +27.8% | +9.0% | +7.1% |
| Profit after Tax | ₹3.78 Cr | -5.7% | +15.0% | +9.2% |
| Net Worth | ₹19.54 Cr | +13.5% | -2.7% | +16.3% |
| Employees | 399 | +25.8% | +5.3% | +15.4% |
Audited financials & ratios for Biocon Pharma Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2014-15 | — | — | -25.00% | -20.00% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,56,09,035 | 66.85% |
| Institutional Investors | 3 | 36,65,344 | 9.57% |
| Public & Others | 37 | 90,34,312 | 23.58% |
Promoter, institutional & public holding for Biocon Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
9 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.